LABD vs. BBC

Last updated Jun 4, 2026

LABD (Direxion Daily S&P Biotech Bear 3x Shares) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 10 years, LABD returned -56.11%/yr vs 7.64%/yr for BBC. At a correlation of -0.94, they often move in opposite directions. LABD charges 1.06%/yr vs 0.79%/yr for BBC.

Performance

LABD vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than BBC's 8.64% return. Over the past 10 years, LABD has underperformed BBC with an annualized return of -56.11%, while BBC has yielded a comparatively higher 7.64% annualized return.

LABD

• 1D: -4.73%
• 1M: 4.70%
• YTD: -29.83%
• 6M: -31.22%
• 1Y: -80.27%
• 3Y*: -49.85%
• 5Y*: -41.45%
• 10Y*: -56.11%

BBC

• 1D: 0.43%
• 1M: -6.52%
• YTD: 8.64%
• 6M: 14.08%
• 1Y: 116.78%
• 3Y*: 19.99%
• 5Y*: -1.96%
• 10Y*: 7.64%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABD vs. BBC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABD Direxion Daily S&P Biotech Bear 3x Shares	-29.83%	-70.07%	-21.43%	-41.77%	-32.68%	1.86%	-89.75%	-70.80%	-6.26%	-75.67%
BBC Virtus LifeSci Biotech Clinical Trials ETF	8.64%	63.77%	-1.11%	-1.80%	-35.13%	-22.31%	30.32%	63.81%	-18.29%	57.85%

Correlation

The correlation between LABD and BBC is -0.92, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.92
Correlation (3Y) Calculated over the trailing 3-year period	-0.92
Correlation (5Y) Calculated over the trailing 5-year period	-0.94
Correlation (10Y) Calculated over the trailing 10-year period	-0.93
Correlation (All Time) Calculated using the full available price history since May 29, 2015	-0.94

The correlation between LABD and BBC has been stable across timeframes, ranging from -0.94 to -0.92 - a consistent structural relationship.

Return for Risk

LABD vs. BBC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD

LABD Risk / Return Rank: 1
LABD Sharpe Ratio Rank: 1
LABD Sortino Ratio Rank: 0
LABD Omega Ratio Rank: 0
LABD Calmar Ratio Rank: 1
LABD Martin Ratio Rank: 2

BBC

BBC Risk / Return Rank: 89
BBC Sharpe Ratio Rank: 92
BBC Sortino Ratio Rank: 87
BBC Omega Ratio Rank: 77
BBC Calmar Ratio Rank: 95
BBC Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABD vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LABD	BBC	Difference
Sharpe ratio: Return per unit of total volatility	-1.06	3.32	-4.38
Sortino ratio: Return per unit of downside risk	-2.22	3.98	-6.20
Omega ratio: Gain probability vs. loss probability	0.75	1.46	-0.71
Calmar ratio: Return relative to maximum drawdown	-0.97	7.78	-8.74
Martin ratio: Return relative to average drawdown	-1.31	24.80	-26.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LABD vs. BBC - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -1.06, which is lower than the BBC Sharpe Ratio of 3.32. The chart below compares the historical Sharpe Ratios of LABD and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LABD	BBC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.06	3.32	-4.38
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	-0.05	-0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.59	0.20	-0.79
Sharpe Ratio (All Time) Calculated using the full available price history	-0.54	0.12	-0.66

Drawdowns

LABD vs. BBC - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.99%, which is greater than BBC's maximum drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for LABD and BBC.

Drawdown Indicators

	LABD	BBC	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-76.85%	-23.14%
Max Drawdown (1Y) Largest decline over 1 year	-83.21%	-15.10%	-68.11%
Max Drawdown (3Y) Largest decline over 3 years	-95.31%	-54.45%	-40.86%
Max Drawdown (5Y) Largest decline over 5 years	-98.24%	-72.44%	-25.80%
Max Drawdown (10Y) Largest decline over 10 years	-99.98%	-76.85%	-23.13%
Current Drawdown Current decline from peak	-99.99%	-30.27%	-69.72%
Average Drawdown Average peak-to-trough decline	-90.92%	-37.14%	-53.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	61.36%	4.73%	+56.63%

Volatility

LABD vs. BBC - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to Virtus LifeSci Biotech Clinical Trials ETF (BBC) at 10.93%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LABD	BBC	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.46%	10.93%	+16.53%
Volatility (6M) Calculated over the trailing 6-month period	61.67%	26.43%	+35.24%
Volatility (1Y) Calculated over the trailing 1-year period	75.77%	35.50%	+40.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.26%	39.31%	+56.95%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.93%	37.74%	+58.19%

LABD vs. BBC - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than BBC's 0.79% expense ratio.

Dividends

LABD vs. BBC - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 6.45%, more than BBC's 1.56% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.56%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
LABD Direxion Daily S&P Biotech Bear 3x Shares	6.45%	6.67%	4.68%	6.13%	0.53%	0.00%	3.94%	1.75%	0.81%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both LABD and BBC in my portfolio?

LABD and BBC have a correlation of -0.92, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LABD or BBC?

LABD has higher volatility (27.46%) compared to BBC (10.93%). In terms of maximum drawdown, LABD dropped -99.99% vs BBC's -76.85%.

Which ETF is better, LABD or BBC?

On 10-year performance, BBC leads with 7.64% vs -56.11% for LABD. On fees, BBC is cheaper at 0.79% per year. On volatility, BBC has been the lower-risk option at 10.93%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, LABD or BBC?

Over the 10-year period, BBC has performed better with a 7.64% return vs -56.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, LABD or BBC?

BBC is cheaper with a 0.79% expense ratio, compared with 1.06% for LABD.

Which ETF pays a higher dividend yield, LABD or BBC?

LABD has the higher dividend yield at 6.45%, compared with 1.56% for BBC.

What is the main difference between LABD and BBC?

LABD is categorized as Leveraged Equities, while BBC is Health & Biotech Equities. LABD tracks S&P Biotechnology Select Industry Index (-300%), while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: Direxion and Virtus Investment Partners. Their fees differ too: 1.06% for LABD and 0.79% for BBC.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (3.32 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.